# Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

> **NCT00031876** · PHASE1,PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 34 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00031876
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031876, "Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00031876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*